Medline (MDLN) is slated to start formal marketing for its IPO as soon as Monday, Bloomberg’s Ryan Gould, Bailey Lipschultz, and Anthony Hughes report, citing people familiar with the matter. The company backed by Blackstone (BX), Carlyle (CG), and Hellman & Friedman anticipates lining up roughly $2B worth of commitments from cornerstone investors before officially taking orders, the authors say, noting that the company had previously targeted an IPO of roughly $5B in total.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BX:
- Blackstone, Apollo, KKR sign up for U.K. stress tests, FT reports
- Midday Fly By: Nvidia invests in Synopsys, U.S. strikes pharma deal with UK
- Blackstone considers abandoning bid for Big Yellow Group, Sky News reports
- M&A News: ServiceNow Is in Advanced Talks to Acquire Veza for $1 Billion
- Blackstone nearing deal for MacLean Power Systems for $4B, Bloomberg reports